These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 26443527)
1. Prophylactic Laparoscopic Total Gastrectomy with Jejunal Pouch Reconstruction in Patients Carrying a CDH1 Germline Mutation. Haverkamp L; van der Sluis PC; Ausems MG; van der Horst S; Siersema PD; Ruurda JP; Offerhaus GJ; van Hillegersberg R J Gastrointest Surg; 2015 Dec; 19(12):2120-5. PubMed ID: 26443527 [TBL] [Abstract][Full Text] [Related]
2. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461 [No Abstract] [Full Text] [Related]
3. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients. Strong VE; Gholami S; Shah MA; Tang LH; Janjigian YY; Schattner M; Selby LV; Yoon SS; Salo-Mullen E; Stadler ZK; Kelsen D; Brennan MF; Coit DG Ann Surg; 2017 Dec; 266(6):1006-1012. PubMed ID: 27759617 [TBL] [Abstract][Full Text] [Related]
4. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748 [TBL] [Abstract][Full Text] [Related]
5. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members. Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748 [TBL] [Abstract][Full Text] [Related]
6. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer]. de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213 [TBL] [Abstract][Full Text] [Related]
7. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies. Vos EL; Salo-Mullen EE; Tang LH; Schattner M; Yoon SS; Gerdes H; Markowitz AJ; Mandelker D; Janjigian Y; Offitt K; Coit DG; Stadler ZK; Strong VE JAMA Surg; 2020 Nov; 155(11):1050-1057. PubMed ID: 32997132 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series. Gjyshi O; Vashi P; Seewald L; Kohan M; Abboud E; Fowler E; Suppiah R; Halabi H World J Surg Oncol; 2018 Jul; 16(1):143. PubMed ID: 30007404 [TBL] [Abstract][Full Text] [Related]
13. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice? Zhang Q; Yang Z; Karamchandani DM Ann Diagn Pathol; 2020 Apr; 45():151473. PubMed ID: 31986421 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic total gastrectomy for individuals with germline CDH1 mutation. Pandalai PK; Lauwers GY; Chung DC; Patel D; Yoon SS Surgery; 2011 Mar; 149(3):347-55. PubMed ID: 20719348 [TBL] [Abstract][Full Text] [Related]
15. Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report. Black MD; Kaneshiro R; Lai JI; Shimizu DM Hawaii J Med Public Health; 2014 Jul; 73(7):204-7. PubMed ID: 25089230 [TBL] [Abstract][Full Text] [Related]
17. Hereditary Diffuse Gastric Cancer Treated by Prophylactic Total Gastrectomy. Inaba Y; Goda K; Kondo M; Abe K; Kanamori A; Suzuki T; Tominaga K; Nakagawa M; Morita S; Kojima K; Ishida K; Irisawa A Intern Med; 2024 Jan; 63(2):235-239. PubMed ID: 37225495 [TBL] [Abstract][Full Text] [Related]
18. Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study. Asif B; Sarvestani AL; Gamble LA; Samaranayake SG; Famiglietti AL; Fasaye GA; Quezado M; Miettinen M; Korman L; Koh C; Heller T; Davis JL Lancet Oncol; 2023 Apr; 24(4):383-391. PubMed ID: 36990610 [TBL] [Abstract][Full Text] [Related]
19. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance. Lim YC; di Pietro M; O'Donovan M; Richardson S; Debiram I; Dwerryhouse S; Hardwick RH; Tischkowitz M; Caldas C; Ragunath K; Fitzgerald RC Gastrointest Endosc; 2014 Jul; 80(1):78-87. PubMed ID: 24472763 [TBL] [Abstract][Full Text] [Related]
20. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer. Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]